Carmine N. Stengone sold $41K of Contineum Therapeutics, Inc. (CTNM) stock

Carmine N. Stengone, CEO and President of Contineum Therapeutics, Inc. (CTNM), sold 2,500 shares of CTNM stock worth $41K, per an SEC Form 4 filed Sep 8, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Sep 8, 2026.

CTNM has moved -15.9% since the trade date, from $15.94 to $13.40 (Sep 22, 2026 close).